Medical management of intracranial atherosclerosis: Current state of the art

Cleveland Clinic Journal of Medicine

Volumn 71, Issue SUPPL.1, 2003, Pages

  Sila, Cathy A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ATHEROSCLEROSIS; HUMAN; REVIEW;

HUMANS; INTRACRANIAL ARTERIOSCLEROSIS;

EID: 84884561154     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.Suppl_1.S47     Document Type: Article

References (11)

1. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985; 313:1191-1200.
2. Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989; 321:501-507.
3. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45:1488-1493.
4. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143:1-13.
5. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348:1329-1339.
6. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998; 29:1389-1392.
7. Benesch CG, Chimowitz MI, for the WASID Investigators. Best treatment for intracranial stenosis? 50 years of uncertainty. Neurology 2000; 55:465-466.
8. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis. Outcome of patients who fail antithrombotic therapy. Neurology 2000; 55:490-497.
9. Mohr JP, Thompson JLP, Lazar RM, et al, for the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345:1444-1451.
10. Torn M, Algra A, Rosendaal FR. Oral anticoagulation for cerebral ischemia of arterial origin: high initial bleeding risk (SPIRIT). Neurology 2001; 57:1993-1999.
11. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress, and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003; 22:106-117.